Search: id:"swepub:oai:lup.lub.lu.se:677d7ab2-55d8-41c7-bc6a-e584955a9f85" >
Hemorrhagic symptom...
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study
- Article/chapterEnglish2006
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:677d7ab2-55d8-41c7-bc6a-e584955a9f85
-
https://lup.lub.lu.se/record/686163URI
-
https://doi.org/10.1111/j.1538-7836.2006.02070.xDOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:1944076URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Objectives: We undertook an international, multicenter study to describe the clinical picture and to estimate the bleeding risk in a group of obligatory carriers of type 3 von Willebrand disease (VWD). Patients and methods: Obligatory carriers (OC) of type 3 VWD were identified by the presence of offspring with type 3 VWD or by being an offspring of a type 3 patient. Normal controls were age- and sex-matched with the obligatory carriers. A physician-administered standardized questionnaire was used to evaluate hemorrhagic symptoms at presentation. A score system ranging from 0 (no symptom) to 3 (hospitalization, replacement therapy, blood transfusion) was used to quantitate bleeding manifestations. Odds ratios were computed for each symptom. Results: Ten centers participated to the study, enrolling a total of 35 type 3 VWD families, with 70 OC. A total of 215 normal controls and 42 OC for type 1 VWD were also included. About 40% of type 3 OC had at least one bleeding symptom compared to 23% of normal controls and 81.8% of type 1 OC (P < 0.0001 by chi-squared test), showing that type 3 OC clearly represent a distinct population from type 1 OC. The clinical situations associated with an increase of bleeding risk in type 3 OC were epistaxis [odds ratio 3.6; 90% confidence intervals (CI) 1.84-21.5], cutaneous bleeding (odds ratio 5.5; 90% CI 2.5-14.1) and postsurgical bleeding (odds ratio 16.3; 90% CI 4.5-59). The severity of bleeding score correlated with the degree of factor (F) VIII reduction in plasma. Conclusions: OC for type 3 VWD represent a distinctive population from type 1 OC. These patients, however, present with more frequent bleeding symptoms in comparison to normal controls, especially in case of significantly low FVIII. Desmopressin and/or tranexamic acid might be useful to prevent or treat bleeding in these cases.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Rodeghiero, F.
(author)
-
Tosetto, A.
(author)
-
Cappelletti, A.
(author)
-
Baudo, F.
(author)
-
Eikenboom, J. C. J.
(author)
-
Federici, A. B.
(author)
-
Lethagen, StefanLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine(Swepub:lu)medf-sle
(author)
-
Linari, S.
(author)
-
Lusher, J.
(author)
-
Nishino, M.
(author)
-
Petrini, P.
(author)
-
Srivastava, A.
(author)
-
Ungerstedt, J. S.Karolinska Institutet
(author)
-
Institutionen för kliniska vetenskaper, MalmöMedicinska fakulteten
(creator_code:org_t)
Related titles
-
In:Journal of Thrombosis and Haemostasis: Elsevier BV4:10, s. 2164-21691538-79331538-7836
Internet link
Find in a library
To the university's database
- By the author/editor
-
Castaman, G.
-
Rodeghiero, F.
-
Tosetto, A.
-
Cappelletti, A.
-
Baudo, F.
-
Eikenboom, J. C. ...
-
show more...
-
Federici, A. B.
-
Lethagen, Stefan
-
Linari, S.
-
Lusher, J.
-
Nishino, M.
-
Petrini, P.
-
Srivastava, A.
-
Ungerstedt, J. S ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
Journal of Throm ...
- By the university
-
Lund University
-
Karolinska Institutet